| ASSET | QUARTER | % RETURN |
|---|---|---|
Treasure Global (TGL) | Q1 2024 | 3,948.66% |
error (ZVZZT) | Q1 2024 | 1,820.04% |
Swvl (SWVL) | Q1 2024 | 640.63% |
Corbus Pharmaceuticals (CRBP) | Q1 2024 | 552.91% |
Skye Bioscience, Inc Common Stock (SKYE) | Q1 2024 | 506.2% |
Root (ROOT) | Q1 2024 | 486.18% |
Zivo Bioscience (ZIVO) | Q1 2024 | 474.07% |
Fitell Corporation Ordinary Shares (FTEL) | Q1 2024 | 420.39% |
Dave (DAVE) | Q1 2024 | 355.71% |
Viking Therapeutics (VKTX) | Q1 2024 | 342.53% |
Jasper Therapeutics (JSPR) | Q1 2024 | 328.61% |
Aptorum Group Ltd Class A (APM) | Q1 2024 | 312.61% |
Beamr Imaging Ltd Ordinary Share (BMR) | Q1 2024 | 310.83% |
BeyondSpring (BYSI) | Q1 2024 | 310.34% |
Sezzle (SEZL) | Q1 2024 | 302.33% |
Airship AI (AISP) | Q1 2024 | 289.94% |
OneMedNet (ONMDW) | Q1 2024 | 288.33% |
Jiuzi (JZXN) | Q1 2024 | 272.47% |
Cardiff Oncology (CRDF) | Q1 2024 | 260.81% |
Super Micro Computer (SMCI) | Q1 2024 | 260.73% |
Janux Therapeutics (JANX) | Q1 2024 | 252.53% |
Trump Media & Technology (DJT) | Q1 2024 | 251.25% |
CEA Industries (BNCWW) | Q1 2024 | 242.11% |
GeneDx (WGS) | Q1 2024 | 238.15% |
FiEE (FIEE) | Q1 2024 | 235.26% |
